Agios Pharma (AGIO) Reports In-Line Q2 EPS

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.41), in-line with the analyst estimate of ($1.41).

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• BMO Capital Upgrades Casey's General Stores (CASY) to Outperform, 'Opportunity Knocks'
• Canaccord Reiterates Buy Rating on Holley (HLLY)
• UBS Upgrades Cytokinetics (CYTK) to Buy